Is optimal angiotensin-converting enzyme inhibitor dosing neglected in elderly patients with heart failure?

@article{Gattis1998IsOA,
  title={Is optimal angiotensin-converting enzyme inhibitor dosing neglected in elderly patients with heart failure?},
  author={Wendy A. Gattis and Rhonda L Larsen and Vic Hasselblad and Bradley Bart and Christopher M. O'Connor},
  journal={American heart journal},
  year={1998},
  volume={136 1},
  pages={43-8}
}
BACKGROUND The benefit of angiotensin-converting enzyme (ACE) inhibitors on mortality in heart failure has been proved in randomized controlled trials. METHODS We prospectively evaluated the prescribing of ACE inhibitors and the prescribing of target ACE inhibitor doses in 43 ambulatory patients with heart failure to identify differences in ACE inhibitor utilization among elderly and nonelderly patients. The prescribed ACE inhibitor dose and other variables were assessed by direct patient… CONTINUE READING

From This Paper

Topics from this paper.
13 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

Similar Papers

Loading similar papers…